Ignite Creation Date:
2024-05-19 @ 5:34 PM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06414889
Status:
RECRUITING
Last Update Posted:
2024-05-22
First Post:
2024-05-10
Brief Title:
Protocol Title Safety and Feasibility of Autologous CD34 Hematopoietic Stem Cells Mobilization and Apheresis in Participants With RUNX1 Familial Platelet Disorder
Sponsor:
MD Anderson Cancer Center
Organization:
MD Anderson Cancer Center
Study Overview
Official Title:
Protocol Title Safety and Feasibility of Autologous CD34 Hematopoietic Stem Cells Mobilization and Apheresis in Participants With RUNX1 Familial Platelet Disorder
Status:
RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To evaluate the safety and feasibility of collecting hematopoietic stem cells HSC in participants with RUNX1-FPD
Detailed Description:
Primary Objective
- To evaluate the safety of harvesting HSCs in participants with RUNX1 FPD
Secondary Objective
- To evaluate the feasibility and other relevant information of collecting HSCs from participants with RUNX1 FPD
- To evaluate the safety of harvesting HSCs in participants with RUNX1 FPD
Secondary Objective
- To evaluate the feasibility and other relevant information of collecting HSCs from participants with RUNX1 FPD
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| NCI-2024-04300 | OTHER | NCI-CTRP Clinical Registry | None |